Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis

Science

Volumn 272, Issue 5268, 1996, Pages 1641-1643

  Sherman, David R ^a   Mdluli, Khisimuzi ^b   Hickey, Mark J ^a   Arain, Taraq M ^a   Morris, Sheldon L ^c   Barry III, Clifton E ^b   Stover, C Kendall ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; ISONIAZID; PEROXIDASE; PEROXIDE;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG ACTIVATION; DRUG RESISTANCE; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS;

EID: 0029996734     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.272.5268.1641     Document Type: Article

References (24)

1. K. Johnsson and P. G. Schultz, J. Am. Chem. Soc. 116, 7425 (1995).
2. Y. Zhang, B. Heym, B. Allen, D. Young, S. Cole, Nature 358, 591 (1992).
3. H. A. Shoeb, B. U. J. Bowman, A. C. Ottolenghi, A. J. Merola, Antimicrob. Agents Chemother. 27, 399 (1985).
4. K. Takayama, L. Wang, H. L. David, ibid. 2, 29 (1972).
5. Y. Yuan, R. E. Lee, G. S. Besra, J. T. Belisle, C. E. Barry III, Proc. Natl. Acad. Sci. U.S.A. 92, 6630 (1995).
6. D. R. Sherman et al., ibid., p. 6625.
7. B. Demple and J. Halbrook, Nature 304, 466 (1983).
8. M. F. Christman, R. W. Morgan, F. S. Jacobson, B. N. Ames, Cell 41, 753 (1985).
9. V. Deretic et al., Mol. Microbiol. 17, 889 (1995).
10. B. Heym, P. M. Alzari, N. Honore, S. T. Cole, ibid. 15, 235 (1995).
11. S. Morris et al., J. Infect. Dis. 171, 954 (1995).
12. T. M. Wilson, G. W. de Lisle, D. M. Collins, Mol. Microbiol. 15, 1009 (1995).
13. J. L. Rosner and G. Storz, Antimicrob. Agents Chemother. 38, 1829 (1994).
14. D. R. Sherman, K. Mdluli, M. J. Hickey, C. E. Barry III, C. K. Stover, unpublished data.
15. A 675-bp sequence upstream of the katG gene of MTB strain Erdman was used to drive expression of the lux gene in an integrating shuttle vector. Fidelity of constructs was determined by sequence analysis. Transformations into BCG and lux assays were done as described (23).
16. S. T. Cole and B. Heym, personal communication.
17. Mid-log H37Rv were diluted and spread on 7H11 plates with INH (0, 0.5, 1.0, and 10 μg/ml). INH-resistant single colony isolates were re-streaked at each level on fresh plates with the same amount of INH, and then bacteria were collected and lysed as described (6). Lysates were probed by protein immunoblot with polyclonal antisera to KatG, and KatG(-) lysates were screened by two-dimensional gel electrophoresis for the up-regulation of AhpC.
18. H. Z. Chae et al., Proc. Natl. Acad. Sci. U.S.A. 91, 7017 (1994).
19. H. Z. Chae, S. J. Chung, S. G. Rhee, J. Biol. Chem. 269, 27670 (1994).
20. B. Wieles, S. Nagai, H. G. Wiker, M. Harboe, T. H. M. Ottenhoff, Infect. Immun. 63, 4946 (1995).
21. H. Sies, Agnew. Chem. Int. Ed. Engl. 25, 1058 (1986).
22. B. Halliwell and J. M. C. Gutteridge, Biochem. J. 219, 1 (1934).
23. M. J. Hickey et al., Antimicrob. Agents Chemother. 40, 400 (1996).
24. We thank Y. Zhu, J. Morgenroth, and D. Crane for technical assistance; E. Tolentino and B. Mansfield and the PathoGenesis Microchemistry Facility for help with sequencing; and J. Reid, S. Altman, L. Shapiro, S. Benkovic, H. Caldwell, and R. Belland for careful review of the manuscript.